Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer

Josephine A. Taverna, Chia Nung Hung, Daniel T. DeArmond, Meizhen Chen, Chun Lin Lin, Pawel A. Osmulski, Maria E. Gaczynska, Chiou Miin Wang, Nicholas D. Lucio, Chih Wei Chou, Chun Liang Chen, Alia Nazarullah, Shellye R. Lampkin, Lianqun Qiu, David J. Bearss, Steven Warner, Clifford J. Whatcott, Lars Mouritsen, Mark Wade, Steven WeitmanRuben A. Mesa, Nameer B. Kirma, Wei Ting Chao, Tim H.M. Huang

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology